Please assess the completion status of the following clinical trial:

Trial Title: Vaginal Estrogen and Pelvic Floor Physical Therapy in Women With Symptomatic Mild Prolapse

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women in good health aged 40-80~* Has symptoms of pelvic organ prolapse; answers yes to at least 1 of the following questions:~Do you feel or see a vaginal bulge? Do you feel pressure in the vagina?~* Meets POP-Q criteria on exam for stage I, II, or III prolapse~* Interested in PFPT for management of POP~* Normal mammogram within 1 year of enrollment~Exclusion Criteria:~* Prior surgery for prolapse or incontinence~* Other prior interventions for prolapse (e.g. pessary, PFPT)~* Previous bilateral salpingo-oophorectomy (women with 1 ovary will be eligible)~* Known liver dysfunction~* Connective tissue diseases known to affect collagen or elastin remodeling (including: Lupus, Rheumatoid Arthritis, Scleroderma, Sjogrens syndrome, Marfan syndrome, and Ehlers-Danlos syndrome)~* Unevaluated abnormal vaginal bleeding or abnormal pap smear in the previous year~* BMI \> 35 kg/m2~* Estrogen therapy (including birth control) in the previous year~* Current or prior breast or pelvic malignancy (ovarian, tubal, uterine, cervical or vaginal)~* Contraindication to hormone use (i.e. thromboembolic disorder, use of anti-coagulants, coronary artery disease, history of stroke)

- Gender: FEMALE
- Minimum Age: 40 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Vaginal estrogen (Type: EXPERIMENTAL): Patients in the experimental group will receive vaginal estrogen cream
- Placebo cream (Type: PLACEBO_COMPARATOR): Patients in the comparison group will receive placebo vaginal cream

Based on this trial design, predict the completion outcome and termination type (if applicable).